Skolnick Phil 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 27, 2021
Insider Transaction Report
Form 4
Skolnick Phil
Chief Scientific Officer
Transactions
- Award
Common Stock
2021-01-26+5,400→ 12,348 total - Award
Common Stock
2021-01-26+2,798→ 6,948 total - Award
Stock Option (right to buy)
2021-01-26+10,750→ 10,750 totalExercise: $12.15Exp: 2031-01-26→ Common Stock (10,750 underlying)
Footnotes (3)
- [F1]2,798 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. 100% of the RSUs vest on the anniversary date of January 26, 2022, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]5,400 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 26, 2022, January 26, 2023, January 6, 2024 and January 26, 2025, subject to the Reporting Person continuing as a service provider through each such date.
- [F3]On January 26, 2021, the reporting person was granted an option to purchase 10,750 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of January 26, 2021, the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the vesting commencement date.